HIV vaccines: can mucosal CD4 T cells be protected?

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• The mucosa is the primary site for Human Immunodeficiency Virus (HIV) transmission and initial viral replication.
• HIV infection rapidly disseminates from mucosal tissues, leading to widespread destruction of memory CD4 T cells.

Purpose of the Study:

• To understand the importance of mucosal tissue protection during acute HIV infection.
• To review current strategies for protecting mucosal immunity against HIV.

Main Methods:

• Review of current scientific literature on HIV mucosal immunology and vaccine development.
• Analysis of viral dissemination pathways and immune responses at mucosal sites.

Main Results:

• Mucosal tissues harbor a high density of susceptible CD4 T cells, making them vulnerable during acute HIV infection.
• Massive CD4 T cell destruction occurs rapidly, both at mucosal sites and systemically, following HIV transmission.

Conclusions:

• Maintaining high alert immune responses in mucosal tissues is essential for controlling HIV.
• Vaccine-induced neutralizing antibodies and CD8 T cell responses are critical for mucosal protection.
• Current research focuses on T cell-based vaccines due to challenges in inducing broadly neutralizing antibodies, with preservation of mucosal CD4 T cells as a key measure of vaccine efficacy.